Literature DB >> 30355762

Higher Positivity Rate with Fourth-Generation QuantiFERON-TB Gold Plus Assay in Low-Risk U.S. Health Care Workers.

Catherine A Hogan1, Sara Tien2, Madhukar Pai3,4, Niaz Banaei5.   

Abstract

Keywords:  latent infection; tuberculosis

Mesh：

Year:  2019        PMID： 30355762      PMCID： PMC6322470          DOI： 10.1128/JCM.01688-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.

Authors:  Madeline L Slater; Gary Welland; Madhukar Pai; Julie Parsonnet; Niaz Banaei
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

Review 2.  Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Authors:  Madhukar Pai; Claudia M Denkinger; Sandra V Kik; Molebogeng X Rangaka; Alice Zwerling; Olivia Oxlade; John Z Metcalfe; Adithya Cattamanchi; David W Dowdy; Keertan Dheda; Niaz Banaei
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

3.  Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.

Authors:  Hee-Won Moon; Rajiv L Gaur; Sara Shu-Hwa Tien; Mary Spangler; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

4.  Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.

Authors:  Elitza S Theel; Heather Hilgart; Margaret Breen-Lyles; Kevin McCoy; Rhiannon Flury; Laura E Breeher; John Wilson; Irene G Sia; Jennifer A Whitaker; Jeremy Clain; Timothy R Aksamit; Patricio Escalante
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

Review 5.  Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?

Authors:  Niaz Banaei; Rajiv L Gaur; Madhukar Pai
Journal:  J Clin Microbiol       Date:  2016-01-13       Impact factor: 5.948
  5 in total
  4 in total

1.  Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.

Authors:  Thara K Venkatappa; Rose Punnoose; Dolly J Katz; Michael P Higgins; Niaz Banaei; Edward A Graviss; Robert W Belknap; Christine S Ho
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

2.  The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting.

Authors:  A Wikell; J Jonsson; R Dyrdak; A J Henningsson; A Eringfält; T Kjerstadius; E Hålldin; H Baqir; V Kholod; E Sturegård; J Bruchfeld; T Schön
Journal:  J Clin Microbiol       Date:  2021-09-22       Impact factor: 5.948

3.  Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.

Authors:  Abdulellah Almohaya; Abdulwahab Aldrees; Layan Akkielah; Alshaima Talal Hashim; Fahad Almajid; Turki Binmoammar; Mazin A Barry
Journal:  Ann Saudi Med       Date:  2020-06-04       Impact factor: 1.526

4.  Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of Mycobacterium tuberculosis Infections in Immunocompromised Patients: a Real-World Study.

Authors:  Yuzhen Xu; Qingluan Yang; Jingyu Zhou; Feiran Zhou; Yufan Hezhang; Yan Gao; Lingyun Shao; Jichan Shi; Qiaoling Ruan; Wenhong Zhang
Journal:  Microbiol Spectr       Date:  2022-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.